LENZ Therapeutics LENZ
NASDAQ LENZ
$4.11 +0.01 (+0.24%)
At close: Nov 11, 2026 · 4:00 PM EST

LENZ Therapeutics (LENZ) Other Non-Current Liabilities (2020 - 2024)

Updated

Analysis

LENZ Therapeutics (LENZ) Other Non-Current Liabilities (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 LENZ Therapeutics 128.82 Mn -839.21 Mn 2.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 64,000.00
Jun 30, 2024 83,000.00
Mar 31, 2024 111,000.00
Dec 31, 2023 992,000.00
Mar 31, 2023 871,000.00
Dec 31, 2022 10.82 Mn
Sep 30, 2022 2.42 Mn
Sep 30, 2021 64,000.00
Jun 30, 2021 64,000.00
Dec 31, 2020 316,000.00
API Access

LENZ Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LENZ&period=max&api_key=YOUR_API_KEY